Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
boston blog main
clinical trials
eli lilly
fda
indiana blog main
2
×
indiana top stories
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
adaptive biotechnologies
alector
allergan
alprazolam
apollomics
bernie sanders
beta bionics
bill & melinda gates foundation trust
black diamond therapeutics
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer drugs
cgrp inhibitors
chronic migraine
civica rx
colucid pharmaceuticals
deals
detroit blog main
detroit top stories
diabets
drug enforcement administration
drug prices
elijah cummings
genentech
generic drugs
What
eli
2
×
giant
pharmaceutical
2
×
acute
addresses
appetite
approval
bio
black
bread
butter
buyout
cancer
cash
causes
condition
decades
diabetes
diamond’s
drug
drugs
fda
friday
giving
grabbed
hasn’t
hold
lasmiditan
lilly
lilly's
lilly’s
lost
loxo
medication
migraine
new
notes
oks
roundup
second
Language
unset
Current search:
eli
×
pharmaceutical
×
amgen
×
" indiana blog main "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More